Department of Dermatology and Venereology, Ibn Rochd University hospital, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
World Journal of Advanced Research and Reviews, 2025, 25(02), 1979-1983
Article DOI: 10.30574/wjarr.2025.25.2.0549
Received on 10 January 2025; revised on 15 February 2025; accepted on 18 February 2025
Infantile hemangiomas (IHs) are the most prevalent benign vascular tumors in pediatric populations, with an incidence of approximately 5 to 10% in infants under one year of age. IHs in the otorhinolaryngological (ENT) region present significant diagnostic and therapeutic challenges due to their potential impact on critical functions such as respiration and phonation.
This study provides a comprehensive analysis of the epidemiological and clinical characteristics, therapeutic modalities, and outcomes of IHs in the ENT region.
Despite therapeutic advancements, the complex nature of IHs in the ENT region necessitates a multidisciplinary approach for optimal management.
This study highlights the imperative of early diagnosis and individualized therapeutic strategies to mitigate complications and enhance patient outcomes.
Infantile Hemangioma (IH); Benign Vascular Tumor; Otorhinolaryngology (ENT); Cervico-Facial Region; Propranolol
Preview Article PDF
Fouzia Hali, Salma Zakaryaa, Bouchra Baghad and Soumiya Chiheb. Management of infantile hemangiomas in the otorhinolaryngological (ENT) region. World Journal of Advanced Research and Reviews, 2025, 25(2), 1979-1983. Article DOI: https://doi.org/10.30574/wjarr.2025.25.2.0549